Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

David A. Barbie, Pablo Tamayo(Broad Institute), Jesse S. Boehm(Broad Institute), So Young Kim(Dana-Farber Cancer Institute), Susan E. Moody(Broad Institute), Ian F. Dunn(Broad Institute), Anna C. Schinzel(Broad Institute), Péter Sandy(Massachusetts Institute of Technology), Etienne Meylan(Massachusetts Institute of Technology), Claudia Scholl(Brigham and Women's Hospital), Stefan Fröhling(Harvard University), Edmond M. Chan(Broad Institute), Martin L. Sos(Max Planck Institute for Metabolism Research), Kathrin Michel(Max Planck Institute for Metabolism Research), Craig H. Mermel(Broad Institute), Serena J. Silver(Broad Institute), Barbara A. Weir(Broad Institute), Jan H. Reiling(Massachusetts Institute of Technology), Qing Sheng, Piyush B. Gupta(Broad Institute), Raymond Wadlow(Broad Institute), Hanh Le(Broad Institute), Sebastian Hoersch(Allen Institute), Ben S. Wittner(Broad Institute), Sridhar Ramaswamy(Broad Institute), David M. Livingston, David M. Sabatini(Broad Institute), Matthew Meyerson(Broad Institute), Roman K. Thomas(Max Planck Society), Eric S. Lander(Broad Institute), Jill P. Mesirov(Broad Institute), David E. Root(Broad Institute), D. Gary Gilliland(Brigham and Women's Hospital), Tyler Jacks(Allen Institute), William C. Hahn(Dana-Farber Cancer Institute)
Nature
October 21, 2009
Cited by 4,174Open Access
Full Text

Abstract


Related Papers